Clinical Trials Browser

Phase 2 × Central Nervous System Neoplasms × Sorafenib × Clear all

NCT00621686 2018-05-08

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 2 Completed

54 enrolled 8 charts

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma